Skip to content
10-Q

Quarterly Report

Voyager Therapeutics, Inc. VYGR

0001104659-25-108846

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 55.6M sh
Shares Diluted Q3 2025 · Sep 30, 2025 58.8M sh
Shares Diluted Q3 2025 · Sep 30, 2025 58.61M sh
Shares Diluted Q3 2025 · Sep 30, 2024 57.85M sh
Shares Diluted Q3 2025 · Sep 30, 2024 57.56M sh
Capex Q3 2025 · Sep 30, 2025 $1.97M
Capex Q3 2025 · Sep 30, 2024 $3.37M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$102.2M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$781K
Cash And Equivalents Q3 2025 · Sep 30, 2025 $45.13M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $71.37M
Stockholders Equity Q3 2025 · Sep 30, 2025 $219.83M
Stockholders Equity Q3 2025 · Jun 30, 2025 $243.94M
Stockholders Equity Q3 2025 · Mar 31, 2025 $272.7M
Stockholders Equity Q3 2025 · Dec 31, 2024 $299.76M
Stockholders Equity Q3 2025 · Sep 30, 2024 $330.31M
Stockholders Equity Q3 2025 · Jun 30, 2024 $335.42M
Stockholders Equity Q3 2025 · Mar 31, 2024 $340.89M
Stockholders Equity Q3 2025 · Dec 31, 2023 $236.32M
Current Liabilities Q3 2025 · Sep 30, 2025 $35.5M
Current Liabilities Q3 2025 · Dec 31, 2024 $49.79M
Total Liabilities Q3 2025 · Sep 30, 2025 $68.49M
Total Liabilities Q3 2025 · Dec 31, 2024 $93.29M
Current Assets Q3 2025 · Sep 30, 2025 $219.59M
Current Assets Q3 2025 · Dec 31, 2024 $276.81M
Total Assets Q3 2025 · Sep 30, 2025 $288.31M
Total Assets Q3 2025 · Dec 31, 2024 $393.05M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.47
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.57
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.16
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.53
Eps Basic Q3 2025 · Sep 30, 2025 −$0.47
Eps Basic Q3 2025 · Sep 30, 2025 −$1.57
Eps Basic Q3 2025 · Sep 30, 2024 −$0.16
Eps Basic Q3 2025 · Sep 30, 2024 −$0.53
Sga Expense Q3 2025 · Sep 30, 2025 $8.09M
Sga Expense Q3 2025 · Sep 30, 2025 $28.23M
Sga Expense Q3 2025 · Sep 30, 2024 $8.17M
Sga Expense Q3 2025 · Sep 30, 2024 $26.93M
Rd Expense Q3 2025 · Sep 30, 2025 $35.87M
Rd Expense Q3 2025 · Sep 30, 2025 $98.72M
Rd Expense Q3 2025 · Sep 30, 2024 $30.24M
Rd Expense Q3 2025 · Sep 30, 2024 $91.79M
Net Income Q3 2025 · Sep 30, 2025 −$27.89M
Net Income Q3 2025 · Sep 30, 2025 −$92.3M
Net Income Q3 2025 · Jun 30, 2025 −$33.38M
Net Income Q3 2025 · Mar 31, 2025 −$31.02M
Net Income Q3 2025 · Sep 30, 2024 −$9.04M
Net Income Q3 2025 · Sep 30, 2024 −$30.52M
Net Income Q3 2025 · Jun 30, 2024 −$10.14M
Net Income Q3 2025 · Mar 31, 2024 −$11.33M
Operating Income Q3 2025 · Sep 30, 2025 −$30.59M
Operating Income Q3 2025 · Sep 30, 2025 −$101.91M
Operating Income Q3 2025 · Sep 30, 2024 −$13.78M
Operating Income Q3 2025 · Sep 30, 2024 −$44.99M
Revenue Q3 2025 · Sep 30, 2025 $13.37M
Revenue Q3 2025 · Sep 30, 2025 $25.04M
Revenue Q3 2025 · Sep 30, 2024 $24.63M
Revenue Q3 2025 · Sep 30, 2024 $73.72M